Expression of vascular cell adhesion molecule-1 in normal and inflamed synovium.

PubWeight™: 1.50‹?› | Rank: Top 4%

🔗 View Article (PMID 7678661)

Published in Lab Invest on January 01, 1993

Authors

L S Wilkinson1, J C Edwards, R N Poston, D O Haskard

Author Affiliations

1: Department of Medicine, Royal Postgraduate Medical School, London.

Articles citing this

Fibroblast biology. Development and differentiation of synovial fibroblasts in arthritis. Arthritis Res (2000) 1.32

The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prostheses. J R Soc Interface (2008) 1.32

GM-CSF, IL-1 alpha, IL-1 beta, IL-6, IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysaccharide, IL-1 alpha and TNF-alpha. Clin Exp Immunol (1994) 1.22

Sustained elevated levels of VCAM-1 in cultured fibroblast-like synoviocytes can be achieved by TNF-alpha in combination with either IL-4 or IL-13 through increased mRNA stability. Am J Pathol (1999) 1.21

Monocyte adhesion to endothelium in simian immunodeficiency virus-induced AIDS encephalitis is mediated by vascular cell adhesion molecule-1/alpha 4 beta 1 integrin interactions. Am J Pathol (1994) 1.14

The nature and origins of synovium: experimental approaches to the study of synoviocyte differentiation. J Anat (1994) 1.14

Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol (1993) 1.10

Palisading cells of rheumatoid nodules: comparison with synovial intimal cells. Ann Rheum Dis (1993) 1.08

The formation of human synovial joint cavities: a possible role for hyaluronan and CD44 in altered interzone cohesion. J Anat (1994) 1.07

Endothelial cell phenotypes in the rheumatoid synovium: activated, angiogenic, apoptotic and leaky. Arthritis Res Ther (2004) 1.07

Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints. Ann Rheum Dis (2003) 1.06

Extracellular matrix of the synovial intimal cell layer. Ann Rheum Dis (1995) 1.04

Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking. Clin Exp Immunol (2002) 0.99

Cell-cell interactions in synovitis. Endothelial cells and immune cell migration. Arthritis Res (2000) 0.93

Synovial macrophages. Ann Rheum Dis (1995) 0.90

Is rheumatoid arthritis a failure of B cell death in synovium? Ann Rheum Dis (1995) 0.87

Expression of CD44 in normal and rheumatoid synovium and cultured synovial fibroblasts. Ann Rheum Dis (1994) 0.86

Vascular cell adhesion molecule 1 and alpha 4 and beta 1 integrins in lymphocyte aggregates in Sjögren's syndrome and rheumatoid arthritis. Ann Rheum Dis (1993) 0.86

Expansion of a unique macrophage subset in rheumatoid arthritis synovial lining layer. Clin Exp Immunol (2008) 0.85

Expression of VCAM-1 and VLA-4 dependent T-lymphocyte adhesion to dermal fibroblasts stimulated with proinflammatory cytokines. Immunology (1996) 0.85

Neovascularisation and the induction of cell adhesion molecules in response to degradation products from orthopaedic implants. Ann Rheum Dis (1995) 0.84

Synovial membrane cellularity and vascularity. Ann Rheum Dis (1995) 0.82

Synovial intimal fibroblasts. Ann Rheum Dis (1995) 0.82

Decrease in circulating endothelial cell adhesion molecule and thrombomodulin levels during oral iloprost treatment in rheumatoid arthritis patients: preliminary results. Rheumatol Int (2005) 0.76

Development of synovial membrane in the temporomandibular joint of the human fetus. Eur J Histochem (2015) 0.76

Distribution in human tissues of the synovial lining-associated epitope recognised by monoclonal antibody 67. J Anat (1996) 0.76

2nd International meeting on synovium cell biology, physiology and pathology. Canterbury, United Kingdom, 21-23 September 1994. Proceedings and abstracts. Ann Rheum Dis (1995) 0.75

Synovium: what's new? BMJ (1995) 0.75

Interleukin 4 increases human synovial cell expression of VCAM-1 and T cell binding. Ann Rheum Dis (1994) 0.75

Aortic VCAM-1: an early marker of vascular inflammation in collagen-induced arthritis. J Cell Mol Med (2016) 0.75

Articles by these authors

Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther (1981) 6.71

The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J Pathol (1981) 3.99

Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol (1986) 2.67

Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. J Immunol (1991) 2.59

Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J Immunol (1991) 2.57

A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J Immunol (1990) 2.55

Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res (2003) 2.45

Association of maternal endothelial dysfunction with preeclampsia. JAMA (2001) 2.17

Cardiac surgery in Wessex: review of 1000 consecutive open-heart procedures. Br Med J (1976) 2.16

IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma. J Immunol (1990) 2.15

Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin. Lancet (1968) 2.14

Remission of inflammatory arthropathy in association with anti-CD20 therapy for non-Hodgkin's lymphoma. Rheumatology (Oxford) (1999) 2.14

Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol (1992) 2.12

Detection of antigen-antibody binding events with the atomic force microscope. Biochemistry (1997) 2.05

Increased inflammatory reactivity in newly formed lining tissue. J Pathol (1983) 2.01

Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Lack of correlation with levels of circulating vascular cell adhesion molecule 1. Arthritis Rheum (1993) 1.97

Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am J Respir Cell Mol Biol (1994) 1.92

IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils. J Immunol (1990) 1.86

B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology (Oxford) (2005) 1.83

Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J Neurol Sci (1989) 1.78

Human gamma interferon increases the binding of T lymphocytes to endothelial cells. Clin Exp Immunol (1985) 1.67

A buffered chromic chloride method of attaching antigens to red cells: use in haemagglutination. J Immunol Methods (1974) 1.67

B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis Rheum (2006) 1.65

Spontaneous rupture of the spleen in rheumatoid arthritis. Ann Rheum Dis (1983) 1.63

Light microscopic characterization of the fibroblast-like synovial intimal cell (synoviocyte). Arthritis Rheum (1992) 1.60

Characterization of a yeast mitochondrial promoter by deletion mutagenesis. Proc Natl Acad Sci U S A (1985) 1.59

Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br J Dermatol (1991) 1.57

Analysis of transcriptional initiation of yeast mitochondrial DNA in a homologous in vitro transcription system. Cell (1982) 1.53

Imaging vascular endothelial activation: an approach using radiolabeled monoclonal antibodies against the endothelial cell adhesion molecule E-selectin. J Nucl Med (1994) 1.51

Clinical outcome after one year following samarium-153 particulate hydroxyapatite radiation synovectomy. Scand J Rheumatol (1996) 1.50

Tetrodotoxin derivatives: chemical structure and blockage of nerve membrane conductance. Science (1967) 1.49

Demonstration of bone marrow derived cells in synovial lining by means of giant intracellular granules as genetic markers. Ann Rheum Dis (1982) 1.49

Diagnostic categories in rheumatology. Ann Rheum Dis (1987) 1.49

ICAM-1 deficiency reduces atherosclerotic lesions in double-knockout mice (ApoE(-/-)/ICAM-1(-/-)) fed a fat or a chow diet. Arterioscler Thromb Vasc Biol (2000) 1.47

Controlled prospective study of the effect on liver function of multiple exposures to halothane. Lancet (1975) 1.46

Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane. Ann Rheum Dis (1994) 1.44

Endothelial activation in monosodium urate monohydrate crystal-induced inflammation: in vitro and in vivo studies on the roles of tumor necrosis factor alpha and interleukin-1. Arthritis Rheum (1997) 1.42

Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. Am J Pathol (1994) 1.42

Identification of a single transcriptional initiation site for the glutamic tRNA and COB genes in yeast mitochondria. Proc Natl Acad Sci U S A (1983) 1.42

Mechanisms of inflammation in gout. Rheumatology (Oxford) (2005) 1.42

Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol (2001) 1.41

Where is the evidence? CMAJ (1993) 1.40

Pathogenesis of crystal-induced inflammation. Curr Rheumatol Rep (2001) 1.40

Initiation of transcription of the yeast mitochondrial gene coding for ATPase subunit 9. Nucleic Acids Res (1983) 1.39

A comparison of the performance of two types of infusion device. Anaesthesia (1992) 1.39

A clinical and echocardiographic study of patients with the hypermobility syndrome. Ann Rheum Dis (1981) 1.39

The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation: a comparison of ultraviolet B erythema and delayed hypersensitivity. J Invest Dermatol (1991) 1.37

Possible involvement of S-nitrosothiols in the activation of guanylate cyclase by nitroso compounds. FEBS Lett (1980) 1.36

Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis. Arthritis Rheum (2000) 1.34

Atypical prion protein in sheep brain collected during the British scrapie-surveillance programme. J Gen Virol (2006) 1.32

Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am Rev Respir Dis (1993) 1.32

Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation (2001) 1.32

An induced extracellular matrix protein reverses the polarity of band 3 in intercalated epithelial cells. Cell (1994) 1.31

Expression of VCAM-1 in the normal and diseased kidney. Nephrol Dial Transplant (1991) 1.30

Vascular endothelial cell expression of ICAM-1 and VCAM-1 at the onset of eliciting contact hypersensitivity in mice: evidence for a dominant role of TNF-alpha. J Immunol (1999) 1.30

A comparative study of the cellular, exudative and histological responses to carrageenan, dextran and zymosan in the mouse. Int J Tissue React (1991) 1.25

Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD. Eur Respir J (2004) 1.25

Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP. J Pharmacol Exp Ther (1984) 1.23

Arrangement of domains, and amino acid residues required for binding of vascular cell adhesion molecule-1 to its counter-receptor VLA-4 (alpha 4 beta 1). J Cell Biol (1994) 1.23

Hyaluronan concentration in non-inflamed and rheumatoid synovium. Br J Rheumatol (1994) 1.22

Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest (1994) 1.22

Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis (2004) 1.21

Entamoeba histolytica and Entamoeba invadens: chromium release from labeled human liver cells in culture. Exp Parasitol (1977) 1.21

Fatty acids and the release of glucagon from isolated guinea-pig islets of Langerhans incubated in vitro. Biochim Biophys Acta (1970) 1.20

Expression of interleukin-1 beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1ra) on asthmatic bronchial epithelium. Am J Respir Crit Care Med (1996) 1.19

Leukocytes: their role in the etiopathogenesis of skin damage in venous disease. J Vasc Surg (1993) 1.19

Inflammatory vasculitis in multiple sclerosis. J Neurol Sci (1985) 1.18

Differential upregulation of intercellular adhesion molecule-1 in coeliac disease. Clin Exp Immunol (1990) 1.16

The apical Cl/HCO3 exchanger of beta intercalated cells. J Biol Chem (1993) 1.14

Repeated B cell depletion in treatment of refractory systemic lupus erythematosus. Ann Rheum Dis (2005) 1.14

T gamma delta cells and their subsets in blood and synovial tissue from rheumatoid arthritis patients. Scand J Immunol (1990) 1.13

TNF-alpha and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice. J Immunol (1999) 1.13

Clinical skills acquired during third-year surgical clerkships. Am J Surg (1993) 1.13

Vessel associated adhesion molecules in normal skin and acute graft-versus-host disease. J Clin Pathol (1991) 1.13

Uridine diphosphoglucose dehydrogenase activity in normal and rheumatoid synovium: the description of a specialized synovial lining cell. Int J Exp Pathol (1993) 1.12

CLIC-1 functions as a chloride channel when expressed and purified from bacteria. J Biol Chem (2000) 1.12

Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis. Br J Rheumatol (1995) 1.12

The prevalence and distribution of macrophages bearing Fc gamma R I, Fc gamma R II, and Fc gamma R III in synovium. Scand J Rheumatol (1990) 1.11

Human dermal microvascular endothelial cells behave like umbilical vein endothelial cells in T-cell adhesion studies. J Invest Dermatol (1987) 1.11

Anesthetic blocking of nerve membrane conductances by internal and external applications. J Neurobiol (1969) 1.11

The antithrombotic and antiinflammatory mechanisms of action of aprotinin. Ann Thorac Surg (2001) 1.11

Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition. Blood (1999) 1.10

Up-regulation and differential expression of the hyaluronan-binding protein TSG-6 in cartilage and synovium in rheumatoid arthritis and osteoarthritis. Osteoarthritis Cartilage (2001) 1.10

Samarium-153-particulate hydroxyapatite radiation synovectomy: biodistribution data for chronic knee synovitis. J Nucl Med (1995) 1.10

Studies into the influence of carrageenan-induced inflammation on articular cartilage degradation using implantation into air pouches. Br J Exp Pathol (1985) 1.10

Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol (1993) 1.10

Biosynthesis of glucagon in isolated pancreatic islets of guinea pigs. Biochem J (1974) 1.08

Expression of adhesion molecules in human intestinal graft-versus-host disease. Clin Exp Immunol (1992) 1.08

Connective tissue abnormalities in MRL/1 mice. Ann Rheum Dis (1986) 1.08

Joint physiology: relevant to the rheumatologist? Br J Rheumatol (1998) 1.08

Differential distribution of Fc gamma RIIIa in normal human tissues and co-localization with DAF and fibrillin-1: implications for immunological microenvironments. Immunology (1998) 1.07

Fatty acids as regulators of glucagon secretion. Nature (1969) 1.07

Membrane properties and esterase activity of synovial lining cells: further evidence for a mononuclear phagocyte subpopulation. Ann Rheum Dis (1982) 1.06

The expression of leukocyte-endothelial adhesion molecules is increased in perennial allergic rhinitis. Am J Respir Cell Mol Biol (1992) 1.05

Detection of immune complexes in serum of patients with ankylosing spondylitis. Ann Rheum Dis (1978) 1.05

Both Fcgamma and complement receptors mediate transfer of immune complexes from erythrocytes to human macrophages under physiological flow conditions in vitro. Clin Exp Immunol (2006) 1.05

An essential role for the interaction between hyaluronan and hyaluronan binding proteins during joint development. J Histochem Cytochem (1998) 1.04

Endothelial expression of VCAM-1 in experimental crescentic nephritis and effect of antibodies to very late antigen-4 or VCAM-1 on glomerular injury. J Immunol (1999) 1.04